Beijing Enterprises Medical and Health Industry Gr : Poll Results at the Annual General Meeting Held on 19 May 2017

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this document, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 2389) POLL RESULTS AT THE ANNUAL GENERAL MEETING HELD ON 19 MAY 2017

At the annual general meeting (the "AGM") of Beijing Enterprises Medical and Health Industry Group Limited (the "Company") held on 19 May 2017, all the proposed resolutions as set out in the notice of the AGM dated 18 April 2017 were taken by poll. The poll results are as follows:

Ordinary Resolutions		Number of Votes (%)
		For	Against
1.	To receive the audited consolidated financial statements and the reports of the directors and auditors for the year ended 31 December 2016.	2,117,795,226 (100%)	0 (0%)
2.	To re-elect Mr. Liu Xue Heng as an executive director of the Company.	2,117,795,226 (100%)	0 (0%)
3.	To re-elect Mr. Wu Yong Xin as an independent non-executive director of the Company.	1,960,200,827 (92.56%)	157,594,399 (7.44%)
4.	To re-elect Mr. Robert Winslow Koepp as a non- executive director of the Company.	2,116,169,226 (99.92%)	1,626,000 (0.08%)
5.	To re-elect Mr. Gary Zhao as an independent non- executive director of the Company.	2,117,501,226 (99.99%)	294,000 (0.01%)
6.	To consider and authorise the board (the "Board") of the directors of the Company (or, if so delegated by the Board, its remuneration committee) to determine the remuneration of the directors.	2,117,795,226 (100%)	0 (0%)
7.	To appoint Messrs Ernst & Young CPA as auditors of the Company and to authorize the Board to fix their remuneration.	2,117,795,226 (100%)	0 (0%)
8.	To give a general mandate to the directors of the Company to repurchase shares of the Company not exceeding 10% of the total number of issued shares of the Company as at the date of this resolution.	2,117,795,226 (100%)	0 (0%)
9.	To give a general mandate to the directors of the Company to issue additional shares of the Company not exceeding 20% of the total number of issued shares of the Company as at the date of this resolution.	2,003,803,193 (94.41%)	118,566,033 (5.59%)
10.	To extend the general mandate granted to the directors of the Company to issue additional shares of the Company by the aggregate number of the shares repurchased by the Company.	2,003,803,193 (94.41%)	118,566,033 (5.59%)

As a majority of the votes were cast in favour of each of the resolutions numbered 1 to 10, all resolutions were duly passed as ordinary resolutions.

As at the date of the AGM, the number of issued shares of the Company was 6,188,952,277 shares. The total number of shares entitling the holders to attend and vote on the resolutions is 6,188,952,277 shares. There were no shares entitling the holder to attend and abstain from voting in favour at the AGM as set out in rule 13.40 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules").

No shareholder of the Company was required under the Listing Rules to abstain from voting on the resolutions at the AGM. None of the shareholders has stated their intention in the Company's circular dated 18 April 2017 to vote against or to abstain from voting on any of the resolutions at the AGM.

The Company's branch share registrar, Union Registrars Limited, acted as the scrutineer for the vote- taking at the AGM.

By Order of the Board of

Beijing Enterprises Medical and Health Industry Group Limited Zhu Shi Xing

Chairman

Hong Kong, 19 May 2017

As at the date of this announcement, the Board comprises seven Executive Directors, namely Mr. Zhu Shi Xing, Mr. Liu Xue Heng, Mr. Gu Shan Chao, Mr. Hu Xiao Yong, Mr. Hu Shiang Chi, Mr. Wang Zheng Chun and Mr. Zhang Jing Ming; one Non-Executive Director, namely Mr. Robert Winslow Koepp and four Independent Non-Executive Directors, namely Mr. Gary Zhao, Mr. Tse Man Kit, Keith, Mr. Wu Yong Xin and Mr. Zhang Yun Zhou.